April 18, 2013
View Full PaperIdentification of Therapeutic Benefit from Revascularization in Patients With Left Ventricular Systolic Dysfunction
Structured PICO
Does revascularization improve survival compared to medical therapy in patients with ischemic cardiomyopathy based on the presence of hibernating myocardium?
P
Population
Patients with ischemic cardiomyopathy and left ventricular systolic dysfunction
I
Intervention
Revascularization
C
Comparator
Medical therapy
O
Outcome
Survivalhard clinical
In patients with ischemic cardiomyopathy, the presence of hibernating myocardium, rather than ischemia, identifies those who may gain a survival benefit from revascularization.
Abstract
Among patients with ischemic cardiomyopathy, hibernating, but not ischemic, myocardium identifies which patients may accrue a survival benefit with revascularization versus medical therapy.
Cite This Study
Ling et al. (Thu,) studied this question.